0

Lenalidomide Impurity 13

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAPB874760711
CAS874760-71-1
Molecular Weight307.26
Molecular FormulaC13H13N3O6

What is the name of the product with CAS number 874760-71-1?

The product is named Lenalidomide Impurity 13.

What is the molecular weight of Lenalidomide Impurity 13?

The molecular weight of Lenalidomide Impurity 13 is 307.26.

What is the molecular formula of Lenalidomide Impurity 13?

The molecular formula of Lenalidomide Impurity 13 is C13H13N3O6.

What is the significance of Lenalidomide Impurity 13 in pharmaceutical research?

Lenalidomide Impurity 13 is important in pharmaceutical research as it is an impurity that needs to be carefully monitored and controlled in the production of lenalidomide.

How is Lenalidomide Impurity 13 identified and characterized in pharmaceutical production?

Lenalidomide Impurity 13 is identified and characterized by its CAS number, molecular weight, and molecular formula.

What are the potential implications of the presence of Lenalidomide Impurity 13 in lenalidomide products?

The presence of Lenalidomide Impurity 13 in lenalidomide products can affect the efficacy and safety of the medication, therefore it is important to minimize its presence.

How is Lenalidomide Impurity 13 regulated in pharmaceutical manufacturing?

Lenalidomide Impurity 13 is regulated by pharmaceutical authorities and quality control measures to ensure it remains within acceptable limits.

What methods are used to detect and quantify Lenalidomide Impurity 13 in pharmaceutical samples?

Analytical methods such as high-performance liquid chromatography (HPLC) are commonly used to detect and quantify Lenalidomide Impurity 13 in pharmaceutical samples.

What are the potential risks associated with elevated levels of Lenalidomide Impurity 13 in lenalidomide products?

Elevated levels of Lenalidomide Impurity 13 in lenalidomide products can lead to reduced efficacy, increased side effects, or other safety concerns for patients.

How can pharmaceutical companies ensure the quality and purity of lenalidomide products regarding the presence of Lenalidomide Impurity 13?

Pharmaceutical companies can employ rigorous testing and quality control procedures to monitor and control the levels of Lenalidomide Impurity 13 in their products, ensuring high quality and purity.

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode